A team of General Electric (NYSE: GE) and Ford (NYSE: G) has been awarded a Defense Production Act contract worth potentially $336M to produce…
Regeneron Pharmaceuticals (Nasdaq: REGN) will supply an additional 1.25M treatment courses of an antibody cocktail composed of casirivimab and imdevimab
According to the Department of Defense, “Serco is being awarded a $14, 320, 218 firm-fixed-price, indefinite-delivery/indefinite-quantity contract to perform hazardous